ArticleScientific reports2026
Frequent coral disease interventions reduces tissue loss.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Markers of resilience to stony coral tissue loss disease and putative probiotic functions in the microbiomes of the coral,ISME communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Stony coral tissue loss disease is a highly contagious coral disease, causing rapid colony mortality and local extinctions. Conducting disease interventions on all corals in a region during an outbreak is virtually impossible, therefore, intervention strategies must be considered. Prioritizing specific colonies for frequent monitoring and treatment can improve disease management outcomes by enabling early disease treatment to reduce colony tissue loss and pathogen load in the environment. Since little is known about the longer-term effectiveness of proactive large scale disease interventions, this study examined the effectiveness of monthly interventions on the largest known Orbicella faveolata colonies in southeast Florida over seven years and forecasted colony fates under present environmental conditions. In 2015, 78 large (> 2 m) O. faveolata colonies were identified and monitored. In 2018, 42 colonies with the greatest living tissue area were designated as priority corals, receiving monthly monitoring with disease interventions, and the remaining 36 colonies were designated non-priority corals and revisited in 2021. All corals lost significant amounts of tissue before disease interventions began (2015–2018). Once monthly monitoring and disease interventions started (2018–2022), tissue loss slowed significantly on the treated priority colonies but continued to decline significantly on the non-priority colonies. Over 66% (24/36) of the non-priority corals died versus none of the priority colonies. While disease interventions were highly successful at reducing the amount of tissue lost to disease, priority corals continually developed new lesions and treatments were still required nearly every month. These frequent treatments are projected to prolong the lifespan of the priority colonies for at least the next 30 years, potentially enabling them to spawn and contribute to the O. faveolata population. Our findings support that disease interventions are a proactive response to SCTLD that saves existing coral genetic diversity and reduces the need for post hoc reef restoration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.